228 related articles for article (PubMed ID: 27846627)
1. Targeting the T Helper 2 Inflammatory Axis in Atopic Dermatitis.
Moreno AS; McPhee R; Arruda LK; Howell MD
Int Arch Allergy Immunol; 2016; 171(2):71-80. PubMed ID: 27846627
[TBL] [Abstract][Full Text] [Related]
2. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
3. Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.
Mizutani N; Sae-Wong C; Kangsanant S; Nabe T; Yoshino S
Immunology; 2015 Dec; 146(4):568-81. PubMed ID: 26310839
[TBL] [Abstract][Full Text] [Related]
4. Past, present, and future for biologic intervention in atopic dermatitis.
Howell MD; Parker ML; Mustelin T; Ranade K
Allergy; 2015 Aug; 70(8):887-96. PubMed ID: 25879391
[TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
6. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang IH; Chung WH; Wu PC; Chen CB
Front Immunol; 2022; 13():1068260. PubMed ID: 36569854
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh2 Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing NF-kappaB-Mediated Thymic Stromal Lymphopoietin Expression and T Helper Type 2 Differentiation.
Ko E; Park S; Lee JH; Cui CH; Hou J; Kim MH; Kim SC
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817146
[TBL] [Abstract][Full Text] [Related]
8. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis.
Jariwala SP; Abrams E; Benson A; Fodeman J; Zheng T
Clin Exp Allergy; 2011 Nov; 41(11):1515-20. PubMed ID: 21672057
[TBL] [Abstract][Full Text] [Related]
9. Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.
Kopalli SR; Annamneedi VP; Koppula S
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889539
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and action mechanisms of a Chinese herbal formula on experimental models of atopic dermatitis.
Wang L; Xian YF; Hu Z; Loo SKF; Ip SP; Chan WY; Lin ZX; Wu JCY
J Ethnopharmacol; 2021 Jun; 274():114021. PubMed ID: 33716079
[TBL] [Abstract][Full Text] [Related]
11. The role of Janus kinase signaling in the pathology of atopic dermatitis.
Guttman-Yassky E; Irvine AD; Brunner PM; Kim BS; Boguniewicz M; Parmentier J; Platt AM; Kabashima K
J Allergy Clin Immunol; 2023 Dec; 152(6):1394-1404. PubMed ID: 37536511
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
[TBL] [Abstract][Full Text] [Related]
13. Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.
Carretero M; Guerrero-Aspizua S; Illera N; Galvez V; Navarro M; García-García F; Dopazo J; Jorcano JL; Larcher F; del Rio M
J Invest Dermatol; 2016 Jan; 136(1):136-45. PubMed ID: 26763433
[TBL] [Abstract][Full Text] [Related]
14. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
[TBL] [Abstract][Full Text] [Related]
15. New Cytokines in the Pathogenesis of Atopic Dermatitis-New Therapeutic Targets.
Klonowska J; Gleń J; Nowicki RJ; Trzeciak M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304837
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 attenuates a murine model of atopic dermatitis through inhibition of langerin-positive DCs migration.
Lin L; Xie M; Chen X; Yu Y; Liu Y; Lei K; Wang D; Zeng J; Zhou J; Zhang L; Zuo D; Sun L
Exp Dermatol; 2018 Sep; 27(9):1015-1022. PubMed ID: 29851146
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of macrophage MAPK/NF-κB pathway and Th2 axis by mangiferin ameliorates MC903-induced atopic dermatitis.
Lu C; Deng S; Liu Y; Yang S; Qin D; Zhang L; Wang RR; Zhang Y
Int Immunopharmacol; 2024 May; 133():112038. PubMed ID: 38621336
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging biologic and small molecule therapies for atopic dermatitis.
Li R; Hadi S; Guttman-Yassky E
Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
[TBL] [Abstract][Full Text] [Related]
19. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis.
Iwasaki M; Nagata K; Takano S; Takahashi K; Ishii N; Ikezawa Z
J Invest Dermatol; 2002 Sep; 119(3):609-16. PubMed ID: 12230502
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous atopic dermatitis-like symptoms in a/a ma ft/ma ft/J flaky tail mice appear early after birth.
Kypriotou M; Boéchat C; Huber M; Hohl D
PLoS One; 2013; 8(7):e67869. PubMed ID: 23844115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
